Drug
131 I 8h9
131 I 8h9: highest development phase Phase 1, developed by Y-mAbs Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Y-mAbs Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| 131 I-8H9 NCT01099644 | Phase 1 | Peritoneal Cancer |
Latest
No recent events.
Follow 131 I 8h9 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.